PRA International, a leading Clinical Research Organization, announces the opening of a Munich office, the company's third office in Germany. PRA's office in Mannheim, Germany, established its initial European presence more than 27 years ago. Since that time, PRA has expanded to numerous locations throughout Western Europe, Eastern Europe and several other global regions.

The new office in Munich provides proximity to major pharmaceutical companies operating in and around that city, as well as access to the area's skilled workforce. Located at Atrium, Riesstrasse 29, the new space will initially house over a dozen employees, with future expansions planned for more than 20 employees in the next 12 months and a total of more than 50 within five years.

PRA has conducted clinical trials in more than 60 countries during its more than 30-year history. Operating in Europe since 1981, PRA has executed over 1,000 studies through its 15 European offices. PRA's European capabilities include:

"We are extremely pleased to broaden our coverage with an additional office in Munich," commented Susan Stansfield, Executive VP of Product Registration for Europe, Africa and Asia-Pacific. "The location in Munich complements our existing offices in Mannheim and Berlin and enables us to more easily cover a wider range of Germany and the surrounding countries."

About PRA International

PRA International is a global Clinical Research Organization providing services through all phases of clinical development. Although we specialize in Oncology, CNS, Respiratory/Allergy, Cardiovascular and Infectious Diseases, we perform studies in all therapeutic areas. PRA has supported over 2,100 clinical trials through its 32 global offices. PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge, enable our project teams to deliver consistent and on time performance for our clients.